Concepedia

Publication | Open Access

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

DOIFull Paper Access

327

Citations

23

References

2020

Year

Steven P. Treon, Jorge J. Castillo, Alan P Skarbnik, Jacob D. Soumerai, Irene M. Ghobrial, Maria Luisa Guerrera, Kirsten Meid, Guang Yang
Blood

Abstract

Treon et al provide early clinical data supporting a theoretical rationale for continuing ibrutinib in patients receiving the drug during COVID-19 illness.

References

YearCitations

Page 1